CD4 T cell dependent tumor immunity stimulated by dendritic cell based vaccine

► DC based vaccine stimulated potent tumor protection. ► This protection is dependent on CD4 T cells in the absence of CD8 T cells. ► Neither CD40 signaling nor IL-12 was indispensable for the activation of dendritic. ► The self-antigen targeted immunotherapy avoided autoimmunity.